The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer

Published:2019-02-04 Issue:4 Volume:39 Page:522-528
ISSN:0144-3615
Container-title:Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Journal of Obstetrics and Gynaecology

Author:

Alabdullah M. L.¹²,Ahmad D. A.³,Moseley P⁴,Madhusudan S.⁴⁵,Chan S⁴,Rakha E.³

Affiliation:

1. Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK;

2. Paediatric Surgery Department, Birmingham Children’s Hospital NHS Trust, Birmingham, UK;

3. Department of Histopathology, Division of Cancer and Stem cells, School of Medicine, University of Nottingham, Nottingham, UK;

4. Department of Oncology, Nottingham University Hospital, Nottingham, UK;

5. Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, UK

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01443615.2018.1534091

Reference21 articles.

1. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer

2. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth

3. A Nuclear Transport Signal in Mammalian Target of Rapamycin Is Critical for Its Cytoplasmic Signaling to S6 Kinase 1

4. The tor pathway: a target for cancer therapy

5. HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of EIF4EBP1 in Tumors;Advances in Clinical Medicine;2024

2. Newly Synthesized Anticancer Purine Derivatives Inhibiting p-EIF4E Using Surface-Modified Lipid Nanovesicles;ACS Omega;2023-10-06

3. Nanoparticles augment the therapeutic window of RT and immunotherapy for treating cancers: pivotal role of autophagy;Theranostics;2023

4. The senescence-associated secretory phenotype in ovarian cancer dissemination;American Journal of Physiology-Cell Physiology;2022-07-01

5. Kir7.1 disease mutant T153I within the inner pore affects K⁺ conduction;American Journal of Physiology-Cell Physiology;2022-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3